RT Journal Article
SR Electronic
T1 The auditory Mismatch Negativity reflects accelerated aging in adults with Down’s Syndrome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.21.20243188
DO 10.1101/2020.12.21.20243188
A1 Avancini, Chiara
A1 Jennings, Sally
A1 Chennu, Srivas
A1 Noreika, Valdas
A1 Le, April
A1 Bekinschtein, Tristan
A1 Walpert, Madeleine
A1 Clare, Isabel
A1 Holland, Anthony
A1 Zaman, Shahid
A1 Ring, Howard
YR 2020
UL http://medrxiv.org/content/early/2020/12/22/2020.12.21.20243188.abstract
AB Down’s Syndrome (DS) is associated with premature and accelerated ageing and a propensity for early-onset Alzheimer’s disease (AD). The early symptoms of dementia in people with DS may reflect frontal lobe vulnerability to amyloid deposition. The Mismatch Negativity (MMN) is a frontocentral component elicited by auditory violations of expected sensory input and it reflects sensory memory and automatic attention switching. In the typically developing (TD) population, the MMN response has been found to decrease with age. In the cross-sectional phase of this study the MMN was used to investigate the premature neurological ageing hypothesis of DS. In the longitudinal phase, we evaluated the MMN as a potential predictor of cognitive decline. The study found that age predicted MMN amplitude in DS but not in those who are TD, showing that the MMN reflects accelerated ageing in DS. However, a follow-up of 34 adults with DS found that neither amplitude nor latency of the MMN predicted cognitive decline one year later.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Medical Research Council, The Health Foundation, Addenbrooke's Charitable Trust, Alzheimer's Research UK Pump Priming Grant - Cambridge Network, Fearnsides Fund, and Marmaduke Sheild Fund funded this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval to conduct the study (reference 14/LO/1411) was given by the National Research Ethics Service (NRES). The Committee had the expertise to assess studies that might include individuals who lacked capacity to consent to participation in research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, CA, upon reasonable request.